Recombinant multi-species TFAP2B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TFAP2B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the AP-2 family of transcription factors. AP-2 proteins form homo- or hetero-dimers with other AP-2 family members and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Specific AP-2 family members differ in their expression patterns and binding affinity for different promoters. This protein functions as both a transcriptional activator and repressor. Mutations in this gene result in autosomal dominant Char syndrome, suggesting that this gene functions in the differentiation of neural crest cell derivatives. [provided by RefSeq, Jul 2008]
The Alternative Names of target: AP-2(beta),AP-2B,AP-2beta,AP2-B,AP2-beta,Activating enhancer-binding protein 2-beta,E130018K07Rik,PDA2,TFAP2B,Tcfap2b,Tfap2b,Transcription factor AP-2-beta

Target products collectionGo to TFAP2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP11674-Ag-1/ GM-Tg-hg-IP11674-Ag-2 Human TFAP2B protein Human
GM-Tg-rg-IP11674-Ag-1/ GM-Tg-rg-IP11674-Ag-2 Rat TFAP2B protein Rat
GM-Tg-mg-IP11674-Ag-1/ GM-Tg-mg-IP11674-Ag-2 Mouse TFAP2B protein Mouse
GM-Tg-cynog-IP11674-Ag-1/ GM-Tg-cynog-IP11674-Ag-2 Cynomolgus/Rhesus macaque TFAP2B protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP11674-Ag-1/ GM-Tg-felg-IP11674-Ag-2 Feline TFAP2B protein Feline
GM-Tg-cang-IP11674-Ag-1/ GM-Tg-cang-IP11674-Ag-2 Canine TFAP2B protein Canine
GM-Tg-bovg-IP11674-Ag-1/ GM-Tg-bovg-IP11674-Ag-2 Bovine TFAP2B protein Bovine
GM-Tg-equg-IP11674-Ag-1/ GM-Tg-equg-IP11674-Ag-2 Equine TFAP2B protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP11674-Ag-1/ GM-Tg-hg-IP11674-Ag-2; GM-Tg-rg-IP11674-Ag-1/ GM-Tg-rg-IP11674-Ag-2;
GM-Tg-mg-IP11674-Ag-1/ GM-Tg-mg-IP11674-Ag-2; GM-Tg-cynog-IP11674-Ag-1/ GM-Tg-cynog-IP11674-Ag-2;
GM-Tg-felg-IP11674-Ag-1/ GM-Tg-felg-IP11674-Ag-2; GM-Tg-cang-IP11674-Ag-1/ GM-Tg-cang-IP11674-Ag-2;
GM-Tg-bovg-IP11674-Ag-1/ GM-Tg-bovg-IP11674-Ag-2; GM-Tg-equg-IP11674-Ag-1/ GM-Tg-equg-IP11674-Ag-2
Products Name TFAP2B protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name TFAP2B
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TFAP2B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.